Loading clinical trials...
Loading clinical trials...
A Phase I/II, Randomized, Placebo-controlled Comparative Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.
Conditions
Interventions
UCMSCs
BMMSCs
+1 more
Locations
1
United States
ISCI / University of Miami Miller School of Medicine
Miami, Florida, United States
Start Date
April 12, 2018
Primary Completion Date
March 23, 2020
Completion Date
February 11, 2021
Last Updated
November 8, 2022
NCT07460960
NCT07237750
NCT07324902
NCT07460856
NCT06277661
NCT06715787
Lead Sponsor
Joshua M Hare
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions